Nav Asha Cancer Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 12-12-2024
- Paid Up Capital ₹ 0.50 M
as on 12-12-2024
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Nav Asha Cancer Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ashutosh Panday, Swagnik Chakrabarti, Abhishek Ghosh, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85190UP2022PTC162268
- Company No.
162268
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nav Asha Cancer Hospital?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashutosh Panday  | Managing Director | 12-Apr-2022 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swagnik Chakrabarti | Director | 12-Apr-2022 | Current |
| Abhishek Ghosh | Director | 12-Dec-2023 | Current |
| Archit Kapoor | Director | 12-Dec-2023 | Current |
| Lalan Singh | Director | 12-Dec-2023 | Current |
| Shahab Usmani | Director | 01-Jan-2023 | Current |
Financial Performance of Nav Asha Cancer Hospital.
Enhance accessibility to Nav Asha Cancer Hospital's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nav Asha Cancer Hospital?
Unlock access to Nav Asha Cancer Hospital's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Apex Ent & Head Neck Superspeciality Cen Tre LlpActive 7 years 4 monthsAshutosh Panday and Shahab Usmani are mutual person
- Remedy Cancer Care Private LimitedActive 5 months 19 days
Ashutosh Panday, Archit Kapoor and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nav Asha Cancer Hospital?
Nav Asha Cancer Hospital has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nav Asha Cancer Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nav Asha Cancer Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
